News Items and Events for the Medical Industry
in South Africa
Zentiva launch Storwin 10 mg, 20 mg and 40 mg tablets (rosuvastati)
Zentiva, a Sanofi Company, is pleased to announce the launch of Storwin tablets.
Storwin Tablets, which contain 10 mg, 20 mg or 40 mg rosuvastatin respectively, is indicated for:
Patients with primary hypercholesterolaemia (Type IIa excluding heterozygous familial hypercholesterolaemia), mixed dyslipidaemia (Type IIb) and hypertriglyceridaemia (Type IV), as an adjunct to diet when response to diet and exercise is inadequate.
For any enquiries please contact the Winthrop Pharmaceuticals Customer Service Tollfree line 0800601228 during office hours.
Merilynn Matthew, Marketing Manager
+27 (0)11 256 3700
Date:Tuesday, September 24, 2013
Information on this page is subject to the terms and conditions as stipulated
and changed from time to time
To advertise on our website e-mail firstname.lastname@example.org